Literature DB >> 20415825

Psoriasis: depression, anxiety, smoking, and drinking habits.

Jennifer Hayes1, John Koo.   

Abstract

Psoriasis is a chronic disease that can negatively impact many aspects of quality of life. Patients with psoriasis may suffer from pain and discomfort from the disease as well as psychological and social difficulties including stigmatization, embarrassment, and social inhibition. Anxiety, depression, smoking, and alcohol abuse have been found to have a higher prevalence among psoriasis patients than healthy controls. These comorbidities have also been found to have a directly negative impact on psoriasis. Awareness of the relationship between psoriasis, psychiatric disorders, and substance abuse is important for dermatologists, as these comorbidities can lead to poor compliance and treatment outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20415825     DOI: 10.1111/j.1529-8019.2010.01312.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  28 in total

1.  Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Authors:  R M Fernandez-Torres; S Paradela; E Fonseca
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

2.  Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study.

Authors:  Kirk Geale; Martin Henriksson; Jussi Jokinen; Marcus Schmitt-Egenolf
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

3.  Rapid improvement of palmoplantar psoriasis after cessation of smoking.

Authors:  Husein H Elahmed
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

4.  Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis.

Authors:  Wenqing Li; Jiali Han; Hyon K Choi; Abrar A Qureshi
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

5.  A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Andrew Sohn; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2011-02

6.  Patient-centered online management of psoriasis: a randomized controlled equivalency trial.

Authors:  Cindy J Chambers; Kory K Parsi; Clayton Schupp; April W Armstrong
Journal:  J Am Acad Dermatol       Date:  2011-09-03       Impact factor: 11.527

7.  Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Authors:  K Abuabara; R S Azfar; D B Shin; A L Neimann; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2010-09       Impact factor: 9.302

Review 8.  Does treatment of psoriasis reduce the risk of cardiovascular disease?

Authors:  Sarah Churton; Liza Brown; Thuzar M Shin; Neil J Korman
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

9.  Psychological Stress and Depression in Psoriasis Patients - a Dermatologist's Perspective.

Authors:  Haris Marios Rigas; Stefana Bucur; Diana Maria Ciurduc; Iuliana Elena Nita; Maria Magdalena Constantin
Journal:  Maedica (Buchar)       Date:  2019-09

10.  Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians.

Authors:  Charlotte Read; April W Armstrong
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.